Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

SPDR S&P Biotech ETF

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

Biotech ETFs to Shine Bright on Coronavirus Vaccine Progress

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Amplify Treatments Testing & Advancements ETF

iShares Genomics Immunology and Healthcare ETF

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Stock indexes and ETFs rocketed higher and are continuing the uptrend in trading Wednesday after Moderna said its coronavirus vaccine generated antibodies in elderly patients for the first time, creating optimism for a swifter economic recovery. Shares of the now notorious biotech gained 6% in trading on Wednesday after a company executive reported to a government [.

Moderna Vaccine Optimism Could Drive Biotech ETFs

ARK Industrial Innovation ETF

Global X Robotics & Artificial Intelligence ETF

Communication Services Select Sector SPDR Fund

SPDR S&P Semiconductor ETF

Here are five tech ETFs to buy if you believe that global technology stocks will continue to enjoy their solid runs in the coming quarters.

The 5 Best Tech ETFs to Buy for Safer Growth

On Friday, the World Health Organization said that the coronavirus pandemic may not be snuffed out so easily, even in the event a vaccine is discovered. The group also explained that there’s no guarantee scientists will even find the panacea.

Biotech ETFs Stumble Amid WHO Outlook On Vaccine

SPDR EURO STOXX 50 ETF

iShares Russell 2000 ETF

Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF

SPDR S&P 500 ETF Trust

Vanguard Total Stock Market ETF

Direxion Work From Home ETF

Here are seven index funds that would make firm foundations for any long-term portfolio, especially new investors looking to diversify.

7 Index Funds To Buy For A Firm Portfolio Foundation

Direxion Daily S&P Biotech Bull 3X Shares

It’s been a memorable, if not unusual, summer of 2020, but it’s not stopping biotech bulls from charging forward. The sector has been on a steady uptrend despite the economic effects of Covid-19.

Biotech Has Been in a Steady Uptrend Even Through Covid-19

Health Care Select Sector SPDR Fund

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

The biotechnology industry appears to have completed a transition from accumulation to consolidation to distribution. A confluence of price support levels around $125 for the iShares Nasdaq Biotechnology ETF (IBB) give a clear potential downside target as further weakness appears likely.

Biotech Sector ETF Breaks Price Support, Downside Target In View

Dynavax Technologies

ImmunoGen

Lexicon Pharmaceuticals

Viking Therapeutics

Xencor

The second half of 2020 is well underway, and with markets recovering, one of the strongest industries leading the charge has been biotech.

5 Speculative Biotechs With 50% to 300% Implied Upside

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q2 earnings releases amid the coronavirus crisis.

How Will Biotech ETFs React to Q2 Earnings Release?

AstraZeneca

Johnson & Johnson

Eli Lilly

Merck

Moderna

Novo Nordisk

Roche Holding AG

Sanofi

The biotech sector had a troubled Q2, as doctor visits were curtailed and new Rx'es were in short supply; R&D efforts were also harmed.

Biotech's Q2:  Lots Of Candidates That May Deliver Alpha

Invesco Dynamic Biotechnology & Genome ETF

6 Best Biotech ETFs to Buy for Cutting-Edge Growth

Defiance Nasdaq Junior Biotechnology ETF

New fund invests in small-cap biotechnology stocks. 

Junior Biotech ETF Debuts

ARK Web x.0 ETF

iShares MSCI USA ESG Optimized ETF

Vanguard ESG US Stock ETF

First Trust Dow Jones Internet Index Fund

O'Shares Global Internet Giants ETF

Invesco NASDAQ Internet ETF

Xtrackers MSCI USA ESG Leaders Equity ETF

Let's check out some ETF areas that will remain solid investment picks even as the coronavirus cases show a sharp spike.

Red Hot ETF Areas Amid the Coronavirus Crisis

Virtus LifeSci Biotech Clinical Trials ETF

ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is one of many biotechnology ETF garnering attention this year amid the race to defeat the coronavirus, but SBIO also offers investors allure that will extend beyond the pandemic. SBIO is a fresh approach relative to legacy funds in the category.

Betting on Biotech With Utility Beyond Covid-19

BioNTech SE

Inovio Pharmaceuticals

Covid-19 could drive biotech stocks for years to come, experts say, as investors try to pinpoint the next big winner to churn out a vaccine or treatment.
The post Why The Coronavirus Pandemic Could Influence Biotech Stocks For Years To Come appeared first on Investor's Business Daily.

Why The Coronavirus Pandemic Could Influence Biotech Stocks For Years To Come

First Trust Cloud Computing ETF

Exchange traded fund investors can explore some of the best performing sub-sectors of tech and how they are contributing to a thriving work-from-home environment. In the recent webcast, Thematic Tech in the New Normal, Phil Mackintosh, Chief Economist, Nasdaq, outlined the current market environment that has been profoundly affected by the coronavirus pandemic and how [.

Thematic Tech ETFs to Access Innovative Growth Ideas

First Trust NASDAQ Cybersecurity ETF

Invesco QQQ

Technology is not just a sector – it is at the heart of every innovative company across sectors, asset classes, and geographies. Some of today’s most resilient companies are heavily invested in and rely upon technology to keep their business running strong.

Thematic Tech in the New Normal

Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.

Late-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain

Global X Cloud Computing ETF

Amplify Online Retail ETF

Here we discuss some ETFs that investors can add to their portfolios amid the worsening coronavirus crisis.

Fight the Spurt in Coronavirus Cases With These ETFs

The race to find a coronavirus vaccine is heating up as the latest positive data from progress in trials are being published.

Biotech ETFs to Gain on Coronavirus Vaccine Progress

Biotech exchange-traded funds moved higher Monday as investors tried to sort through winners and losers of the most recent round of COVID-19 treatment results.

Biotech ETFs trade higher on coronavirus treatment news

ProShares Long Online/Short Stores ETF

Amplify Cybersecurity ETF

First Trust Nasdaq Artificial Intelligence & Robotics ETF

In the current scenario, the rising work-from-home and online shopping trend, increasing digital payments, growing video streaming and soaring video game sales are slowly becoming the "new normal."

4 ETF Areas to Keep Soaring as Coronavirus Cases Rise

The iShares Nasdaq Biotechnology ETF (IBB) is among the biotechnology ETFs that are shining this year as companies scramble to develop treatments and vaccines to aid in the fight against the novel coronavirus. IBB, which tracks the Nasdaq Biotechnology Index (NBI), is the largest biotech ETF by assets and while it offers a cap-weighted approach, [.

News for iShares Nasdaq Biotechnology ETF ETF (IBB)